Market Opens

Jonathan M. Wellum, President & CEO, Rocklinc Investment Partners Inc. (“Rocklin” or the “Company”), and his team, joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange (“TSX”), to open the market to celebrate Canada’s newest ETF provider and the launch of their first ETF: Rocklinc Principled Equity ETF (TSX: RKLC). The Rocklinc Principled Equity ETF is designed for Canadian investors seeking prudent, long-term total returns (income and capital gains). The ETF holds a concentrated portfolio of 15–25 global stocks, using a disciplined, research-driven approach to identify and patiently hold high-quality securities trading below their intrinsic value. Rocklinc Investment Partners Inc. is an independent research-driven investment management firm based in Burlington, Ontario, focusing solely on creating portfolios of high-quality assets customized to clients’ investment goals and objectives. Founded in 2010, Rocklinc emphasizes value investing principles, serving private individuals, families, corporations, and foundations with a commitment to honesty, transparency, confidentiality, and consistent results.

Leor Rotchild, Founder, Calgary Climate Week and other members, joined Ariane Bourassa, Head, Sustainability and ESG Strategy, TMX Group, to close the market and celebrate the launch of Calgary Climate Week 2026 from the Energy Transition Centre in Calgary. Calgary Climate Week is a city-wide celebration of climate leadership, innovation, and community action. Taking place June 1–6, 2026, the event brings together investors, climate-tech innovators, policymakers, and community changemakers for a week of forums, tours, demonstrations, and collaborative programming showcasing practical climate solutions. Calgary Climate Week provides a platform for discussing progress and accelerating action towards Calgary's climate goals, including reducing GHG emissions to net-zero by 2050. The Calgary Climate Week was announced as part of Canada Climate Week Xchange (CCWX) event, in partnership with TMX Group and featuring sessions from the Energy Futures Lab, Evok Innovations, and the launch of Calgary Climate Week.

Joseph van den Elsen, President and Chief Executive Officer, Andina Copper Corporation (“Company”) (TSXV: ANDC), and his team, joined Tim Babcock, President, TSX Venture Exchange, TMX Group, to open the market and celebrate the Company's new listing on TSX Venture Exchange. Andina Copper Corporation is a unique South America focused copper explorer listed on the TSX Venture Exchange (TSXV:ANDC), Frankfurt (FSE: FIR), and OTC (OTCQB: PMMCF) exchanges with projects in Argentina, Colombia and Chile. The Company’s strategy is to acquire copper projects with compelling scale and grade and to add value through rapid exploration, and is actively working across two significant discoveries along the world’s premier copper producing belt, and a compelling undrilled copper-gold target. The Piuquenes project is a high-grade copper-gold porphyry located along the San Juan, Argentina Miocene belt, Cobrasco is an exciting new copper-moly porphyry discovery in Chocó, Colombia and Mantau is an undrilled copper-gold target located in the Tier 1 address of Antofagasta, Chile.

Erez Tetro, Chief Executive Officer, VVT Medical Inc. (“VVT”, “VVT Medical”, or the “Company”) (TSXV: VVTM) and his team, joined Dani Lipkin, Managing Director, Global Listings, Toronto Stock Exchange (“TSX”), to open the market and celebrate the Company's new listing on TSX Venture Exchange. VVT Medical is addressing the rapidly expanding $60B global vein-care market, where more than 40 million Americans suffer from varicose veins but fewer than 3% receive treatment. As the field shifts decisively toward non-thermal, minimally invasive solutions, VVT is uniquely positioned with ScleroSafe and V-Block, an intuitive, anesthesia-free platform that treats a broad range of vein diameters without capital equipment or extensive staffing. By combining controlled injection with simultaneous aspiration, the system streamlines procedures, minimizes complications, and supports both medical and aesthetic outcomes. With strong alignment to market demand, cost efficiency for providers, and a technology suite designed for easy adoption, VVT is well-positioned for accelerated global growth.